Breakthrough vaccine could eradicate breast cancer by 2030

The most common cancer in women — and one of the deadliest — may have finally met its match.

Development of a breakthrough vaccine researchers say could eradicate breast cancer by 2030 wrapped up phase one of its clinical trial this week, with more than 75% of women showing a strong immune response, as measured by antibodies on their white blood cells.

The vaccine is aimed at both preventing and treating breast cancer — which affects one in eight women. 5

“It’s very exciting,” said Dr. Amit Kumar, CEO of Anixa Biosciences, which is designing the vaccine along with the Cleveland Clinic.

During the trial’s first phase, researchers gave the vaccine to 35 women , most of them with triple negative breast cancer — the most lethal form . It’s the type that famously led Angelina Jol